Insiders Aren’t Buying Pfizer Stock, and That Could Help
Pfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
Uncover ways to make passive income at home. This article provides strategies to help you earn without constant effort.
16,710 articlesPfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
SoFi posted stronger Q1 2026 results, but the stock remains depressed as investors weigh the path to sustained profit...
In May 2026, mainstream banks are quietly embracing tokenization as infrastructure, not ideology. Experts say crypto ...
A new Fed chair could reshape policy and markets. This guide explains chair kevin warsh plans, the potential economic...
Groupon is charting a new path in local commerce as 2025 earnings loom. This guide breaks down the drivers, risks, an...
Travel demand is returning, but 2026 presents varied challenges for United Airlines. This guide breaks down the Unite...
Warner Bros Discovery trades below $30 as streaming momentum and a robust film slate raise bets on a profitability tu...
When a CEO sells 38,000 Innodata shares, investors often wonder if the move signals trouble or simply a personal liqu...
Actors ratified a four-year pact with studios and streaming platforms, securing pay raises and safeguards on AI usage...
A landmark $1.5 billion bet on counter-drone tech sets Motorola Solutions up for deeper public-safety leadership. Her...
Bernstein analysts say Bitcoin’s ‘boring’ cycle persists and the store-of-value thesis remains intact despite $2.6 bi...
In this edition of the Morning Minute, Saylor is back to buying, signaling renewed confidence in Bitcoin. We break do...